(Q45861904)

17 December 2017

title

Soluble TNF-α receptor secretion from healthy or dystrophic mice after AAV6-mediated muscle gene transfer (English)

1 reference

17 December 2017

0 references

G Moulay

1

1 reference

17 December 2017

C Masurier

2

1 reference

17 December 2017

P Bigey

3

1 reference

17 December 2017

D Scherman

4

1 reference

17 December 2017

A Kichler

5

1 reference

17 December 2017

publication date

1 July 2010

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

17

1 reference

17 December 2017

issue

11

1 reference

17 December 2017

page(s)

1400-1410

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/gt.2010.94

exact match

0 references

cites work

Corticosteroid treatment and functional improvement in Duchenne muscular dystrophy: long-term effect

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.94

A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.94

TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.94

Anti-TNFalpha (Remicade) therapy protects dystrophic skeletal muscle from necrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.94

Viral serotype and the transgene sequence influence overlapping adeno-associated viral (AAV) vector-mediated gene transfer in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.94

Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.94

Posttranslational modifications of recombinant myotube-synthesized human factor IX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.94

Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.94

Antiangiogenic effect of interleukin-10 in ischemia-induced angiogenesis in mice hindlimb

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.94

Gene therapy of collagen-induced arthritis by electrotransfer of human tumor necrosis factor-alpha soluble receptor I variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.94

Role of tumour necrosis factor alpha, but not of cyclo-oxygenase-2-derived eicosanoids, on functional and morphological indices of dystrophic progression in mdx mice: a pharmacological approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.94

Immune evasion by muscle-specific gene expression in dystrophic muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.94

Systemic protein delivery by muscle-gene transfer is limited by a local immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.94

Anti-monocyte chemoattractant protein-1 gene therapy inhibits vascular remodeling in rats: blockade of MCP-1 activity after intramuscular transfer of a mutant gene inhibits vascular remodeling induced by chronic blockade of NO synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.94

Efficient suppression of murine arthritis by combined anticytokine small interfering RNA lipoplexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.94

Phenotypic improvement of dystrophic muscles by rAAV/microdystrophin vectors is augmented by Igf1 codelivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.94

Adeno-associated virus vector-mediated gene transfer into dystrophin-deficient skeletal muscles evokes enhanced immune response against the transgene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.94

Immunity to adeno-associated virus-mediated gene transfer in a random-bred canine model of Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.94

Major role of local immune responses in antibody formation to factor IX in AAV gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.94

Prevention of pathology in mdx mice by expression of utrophin: analysis using an inducible transgenic expression system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.94

Body-wide gene therapy of Duchenne muscular dystrophy in the mdx mouse model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.94

PTC124 targets genetic disorders caused by nonsense mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.94

Utrophin upregulation for treating Duchenne or Becker muscular dystrophy: how close are we?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.94

MUSEAP, a novel reporter gene for the study of long-term gene expression in immunocompetent mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.94

Intracellular trafficking of adeno-associated virus vectors: routing to the late endosomal compartment and proteasome degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.94

Erythropoietin secretion and physiological effect in mouse after intramuscular plasmid DNA electrotransfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.94

7 January 2021

Interleukin-10 expression after intramuscular DNA electrotransfer: kinetic studies

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.94

7 January 2021

Plasmid electrotransfer of eye ciliary muscle: principles and therapeutic efficacy using hTNF-alpha soluble receptor in uveitis

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.94

7 January 2021

Common pathological mechanisms in mouse models for muscular dystrophies

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.94

7 January 2021

Expression of tumor necrosis factor-alpha in regenerating muscle fibers in inflammatory and non-inflammatory myopathies.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.94

7 January 2021

Reduced necrosis of dystrophic muscle by depletion of host neutrophils, or blocking TNFalpha function with Etanercept in mdx mice

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.94

7 January 2021

Sustained AAV-mediated dystrophin expression in a canine model of Duchenne muscular dystrophy with a brief course of immunosuppression

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.94

7 January 2021

Identifiers

DOI

10.1038/GT.2010.94

1 reference

17 December 2017

Dimensions Publication ID

0 references

1 reference

17 December 2017